CDIAS PSMG: Charles Neighbors, Megan O'Grady, Ashly Jordan, and Yuhua Bao
Leveraging regulatory flexibility for methadone take-home dosing to improve retention in treatment for opioid use disorder: A stepped-wedge randomized trial to facilitate clinic level changes.
Charles Neighbors, MBA, PhD
NYU Grossman School of Medicine
Megan O’Grady, PhD
University of Connecticut
Ashly Jordan, PhD, MPH
New York State Office of Addiction Services and Supports
Yubua Bao, PhD
Weill Cornell Medicine
ABSTRACT:
Methadone is a highly effective medication for treating opioid use disorders (OUD) that is provided in opioid treatment programs (OTPs). Recent federal regulatory changes have relaxed criteria for take-home dosing of methadone, offering an opportunity to improve the OUD care experience for patients. Implementing more flexible take-home dosing policies and practices in OTPs may help improve treatment access and outcomes. However, implementation of more flexible take-home dosing in response to federal policy changes has been uneven in OTPs. This stems from multi-level barriers, such as staff concerns for patient safety, financial concerns due to changes (or lack thereof) in payment models, and rigid organizational policies and practices. This presentation will describe a multi-component intervention designed as part of an academic-government partnership to address implementation barriers at multiple levels. We will specifically highlight successes and challenges in using data-based feedback and a financial tool to support OTP implementation of more flexible methadone take-home dosing practices.
